• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用新指南并结合专用 FDG PET/CT 诊断孤立性心脏结节病的临床特征和预后。

Clinical features and prognosis of isolated cardiac sarcoidosis diagnosed using new guidelines with dedicated FDG PET/CT.

机构信息

Department of Radiology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan.

Department of Cardiology, Pulmonology, Hypertension and Nephrology, Ehime University Graduate School of Medicine, Toon, Japan.

出版信息

J Nucl Cardiol. 2023 Feb;30(1):280-289. doi: 10.1007/s12350-022-03034-0. Epub 2022 Jul 8.

DOI:10.1007/s12350-022-03034-0
PMID:35804283
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9984349/
Abstract

BACKGROUND

Diagnostic guidelines for isolated cardiac sarcoidosis (iCS) were first proposed in 2016, but there are few reports on the imaging and prognosis of iCS. This study aimed to evaluate the use of F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) imaging in predicting iCS prognosis.

METHODS AND RESULTS

We retrospectively reviewed the clinical and imaging data of 306 consecutive patients with suspected CS who underwent FDG PET/CT with a dedicated preparation protocol and included 82 patients (55 with systemic sarcoidosis including cardiac involvement [sCS], 27 with iCS) in the study. We compared the FDG PET/CT findings between the two groups. We examined the relationship between the CS type and the rate of adverse cardiac events. The iCS group had a significantly lower target-to-background ratio than the sCS group (P = 0.0010). The event-free survival rate was significantly lower in the iCS group than the sCS group (log-rank test, P < 0.0001). iCS was identified as an independent prognostic factor for adverse events (hazard ratio 3.82, P = 0.0059).

CONCLUSION

iCS was an independent prognostic factor for adverse cardiac events in patients with CS. The clinical diagnosis of iCS based on FDG PET/CT and new guidelines may be important.

摘要

背景

孤立性心脏结节病(iCS)的诊断指南于 2016 年首次提出,但关于 iCS 的影像学表现和预后的报道较少。本研究旨在评估 F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG PET/CT)成像在预测 iCS 预后中的作用。

方法和结果

我们回顾性分析了 306 例疑似 CS 患者的临床和影像学资料,这些患者均采用专用准备方案进行 FDG PET/CT 检查,其中 82 例(55 例系统性结节病包括心脏受累 [sCS],27 例 iCS)纳入本研究。我们比较了两组 FDG PET/CT 结果。我们检查了 CS 类型与不良心脏事件发生率之间的关系。iCS 组的靶-背景比显著低于 sCS 组(P = 0.0010)。iCS 组的无事件生存率显著低于 sCS 组(对数秩检验,P < 0.0001)。iCS 是不良事件的独立预后因素(危险比 3.82,P = 0.0059)。

结论

iCS 是 CS 患者不良心脏事件的独立预后因素。基于 FDG PET/CT 和新指南的 iCS 临床诊断可能很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f345/9984349/3c4fb3fe2aeb/12350_2022_3034_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f345/9984349/0e61e9da7614/12350_2022_3034_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f345/9984349/a559a0e2bd7c/12350_2022_3034_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f345/9984349/3c4fb3fe2aeb/12350_2022_3034_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f345/9984349/0e61e9da7614/12350_2022_3034_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f345/9984349/a559a0e2bd7c/12350_2022_3034_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f345/9984349/3c4fb3fe2aeb/12350_2022_3034_Fig3_HTML.jpg

相似文献

1
Clinical features and prognosis of isolated cardiac sarcoidosis diagnosed using new guidelines with dedicated FDG PET/CT.采用新指南并结合专用 FDG PET/CT 诊断孤立性心脏结节病的临床特征和预后。
J Nucl Cardiol. 2023 Feb;30(1):280-289. doi: 10.1007/s12350-022-03034-0. Epub 2022 Jul 8.
2
Clinical characteristics of definite or suspected isolated cardiac sarcoidosis: application of cardiac magnetic resonance imaging and 18F-Fluoro-2-deoxyglucose positron-emission tomography/computerized tomography.明确或疑似孤立性心脏结节病的临床特征:心脏磁共振成像和 18F-氟-2-脱氧葡萄糖正电子发射断层扫描/计算机断层扫描的应用。
J Card Fail. 2015 Apr;21(4):313-22. doi: 10.1016/j.cardfail.2014.12.004. Epub 2014 Dec 13.
3
FDG uptake patterns in isolated and systemic cardiac sarcoidosis.孤立性和系统性心脏结节病的 FDG 摄取模式。
J Nucl Cardiol. 2023 Jun;30(3):1065-1074. doi: 10.1007/s12350-022-03106-1. Epub 2022 Oct 3.
4
Utility of new FDG-PET/CT guidelines for diagnosing cardiac sarcoidosis in patients with implanted cardiac pacemakers for atrioventricular block.新 FDG-PET/CT 指南在诊断因房室传导阻滞植入心脏起搏器的患者心脏结节病中的应用。
Sci Rep. 2024 Apr 3;14(1):7825. doi: 10.1038/s41598-024-58475-z.
5
The Utility of Whole Body F-FDG PET-CT in Diagnosing Isolated Cardiac Sarcoidosis: The Western Australian Cardiac Sarcoid Study.全身 F-FDG PET-CT 在诊断孤立性心脏结节病中的效用:西澳大利亚心脏结节病研究。
Heart Lung Circ. 2020 Jan;29(1):e1-e6. doi: 10.1016/j.hlc.2019.07.007. Epub 2019 Aug 23.
6
Diagnosis of isolated cardiac sarcoidosis based on new guidelines.根据新指南诊断孤立性心脏结节病。
ESC Heart Fail. 2020 Oct;7(5):2662-2671. doi: 10.1002/ehf2.12853. Epub 2020 Jun 24.
7
Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.心脏正电子发射断层扫描增强了疑似心脏结节病患者的预后评估。
J Am Coll Cardiol. 2014 Feb 4;63(4):329-36. doi: 10.1016/j.jacc.2013.09.022. Epub 2013 Oct 16.
8
Diagnostic performance of F-18 FDG PET for detection of cardiac sarcoidosis; A systematic review and meta-analysis.18F-FDG PET 对心脏结节病检测的诊断性能:系统评价和荟萃分析。
J Nucl Cardiol. 2020 Dec;27(6):2103-2115. doi: 10.1007/s12350-018-01582-y. Epub 2019 Jan 2.
9
FDG-PET/CT and rest myocardial perfusion imaging to predict high-degree atrioventricular block recovery in cardiac sarcoidosis.氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描和静息心肌灌注显像预测心脏结节病高房室传导阻滞的恢复。
J Nucl Cardiol. 2023 Dec;30(6):2490-2500. doi: 10.1007/s12350-023-03306-3. Epub 2023 May 31.
10
Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis.心脏磁共振成像/氟脱氧葡萄糖正电子发射断层显像联合检查用于鉴别活动性与慢性心脏结节病
JACC Cardiovasc Imaging. 2022 Mar;15(3):445-456. doi: 10.1016/j.jcmg.2021.08.018. Epub 2021 Oct 13.

引用本文的文献

1
Characteristics and outcomes of hospitalized patients with Isolated and systemic cardiac sarcoidosis: Analysis of the Nationwide readmissions database 2016-2021.孤立性和系统性心脏结节病住院患者的特征与结局:对2016 - 2021年全国再入院数据库的分析
Int J Cardiol Heart Vasc. 2025 Feb 24;57:101636. doi: 10.1016/j.ijcha.2025.101636. eCollection 2025 Apr.
2
Role of Textural Analysis Parameters Derived from FDG PET/CT in Diagnosing Cardiac Sarcoidosis.基于FDG PET/CT的纹理分析参数在心脏结节病诊断中的作用
World J Nucl Med. 2024 Jul 12;23(4):256-263. doi: 10.1055/s-0044-1788336. eCollection 2024 Dec.
3
Current Practices and Emerging Therapies to Optimize Heart Failure Management in Cardiac Sarcoidosis: A Systematic Review.

本文引用的文献

1
F-FDG/N-ammonia cardiac PET findings in ATTR cardiac amyloidosis.ATTR 心肌淀粉样变的 F-FDG/N-氨心脏 PET 表现。
J Nucl Cardiol. 2023 Apr;30(2):726-735. doi: 10.1007/s12350-021-02886-2. Epub 2022 Jan 27.
2
Clinical outcomes of patients with isolated cardiac sarcoidosis confirmed by clinical diagnostic criteria.临床诊断标准确诊的孤立性心脏结节病患者的临床转归。
Int J Cardiol. 2021 Dec 15;345:49-53. doi: 10.1016/j.ijcard.2021.10.150. Epub 2021 Oct 29.
3
Identification of a novel presumed cardiac sarcoidosis category for patients at high risk of disease.
优化心脏结节病心力衰竭管理的当前实践与新兴疗法:一项系统评价
Cureus. 2024 Aug 9;16(8):e66515. doi: 10.7759/cureus.66515. eCollection 2024 Aug.
4
Utility of new FDG-PET/CT guidelines for diagnosing cardiac sarcoidosis in patients with implanted cardiac pacemakers for atrioventricular block.新 FDG-PET/CT 指南在诊断因房室传导阻滞植入心脏起搏器的患者心脏结节病中的应用。
Sci Rep. 2024 Apr 3;14(1):7825. doi: 10.1038/s41598-024-58475-z.
5
Motion correction for diagnosis of cardiac sarcoidosis-do we have all the answers?用于心脏结节病诊断的运动校正——我们有所有答案了吗?
J Nucl Cardiol. 2023 Oct;30(5):1886-1889. doi: 10.1007/s12350-023-03330-3. Epub 2023 Jul 25.
6
Evaluation of isolated cardiac sarcoidosis applying updated Japanese guidelines.应用更新后的日本指南对孤立性心脏结节病进行评估。
J Nucl Cardiol. 2023 Feb;30(1):290-291. doi: 10.1007/s12350-022-03172-5. Epub 2023 Jan 28.
7
FDG uptake patterns in isolated and systemic cardiac sarcoidosis.孤立性和系统性心脏结节病的 FDG 摄取模式。
J Nucl Cardiol. 2023 Jun;30(3):1065-1074. doi: 10.1007/s12350-022-03106-1. Epub 2022 Oct 3.
鉴定一类新型疑似心脏结节病,此类患者具有较高的患病风险。
Int J Cardiol. 2021 Jul 15;335:66-72. doi: 10.1016/j.ijcard.2021.04.022. Epub 2021 Apr 18.
4
Diagnosis of isolated cardiac sarcoidosis based on new guidelines.根据新指南诊断孤立性心脏结节病。
ESC Heart Fail. 2020 Oct;7(5):2662-2671. doi: 10.1002/ehf2.12853. Epub 2020 Jun 24.
5
JCS 2016 Guideline on Diagnosis and Treatment of Cardiac Sarcoidosis - Digest Version.《日本循环学会2016年心脏结节病诊断与治疗指南 - 摘要版》
Circ J. 2019 Oct 25;83(11):2329-2388. doi: 10.1253/circj.CJ-19-0508. Epub 2019 Oct 9.
6
Recommendations for F-fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis-2018 update: Japanese Society of Nuclear Cardiology recommendations.2018年更新版:日本核心脏病学会关于¹⁸F-氟脱氧葡萄糖正电子发射断层显像用于心脏结节病诊断的建议
J Nucl Cardiol. 2019 Aug;26(4):1414-1433. doi: 10.1007/s12350-019-01755-3.
7
Myocardial Involvement in Patients With Histologically Diagnosed Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis of Gross Pathological Images From Autopsy or Cardiac Transplantation Cases.组织学诊断为心脏结节病患者的心肌受累:尸检或心脏移植病例大体病理图像的系统评价和荟萃分析。
J Am Heart Assoc. 2019 May 21;8(10):e011253. doi: 10.1161/JAHA.118.011253.
8
Prevalence of F-fluorodeoxyglucose positron emission tomography abnormalities in patients with arrhythmogenic right ventricular cardiomyopathy.致心律失常性右室心肌病患者 F-氟代脱氧葡萄糖正电子发射断层扫描异常的发生率。
Int J Cardiol. 2019 Jun 1;284:99-104. doi: 10.1016/j.ijcard.2018.10.083. Epub 2018 Oct 26.
9
Volume-based glucose metabolic analysis of FDG PET/CT: The optimum threshold and conditions to suppress physiological myocardial uptake.基于体积的 FDG PET/CT 葡萄糖代谢分析:抑制生理性心肌摄取的最佳阈值和条件。
J Nucl Cardiol. 2019 Jun;26(3):909-918. doi: 10.1007/s12350-017-1122-6. Epub 2017 Dec 14.
10
Joint SNMMI-ASNC Expert Consensus Document on the Role of F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring.SNMMI-ASNC关于F-FDG PET/CT在心脏结节病检测和治疗监测中作用的联合专家共识文件。
J Nucl Med. 2017 Aug;58(8):1341-1353. doi: 10.2967/jnumed.117.196287.